LABORATORIES
Developmental neurobiology group-GNDe
Developmental neurobiology group-GNDe
Research
Team
Publications
Contact
Others
Research
Team
Fernando de Castro Soubriet
Principal Investigator
PhD students
Carolina Melero Jerez
Sonia Nocera (I)
Technicians
Mario Lozano Enguita
Others
Pablo Sosa (graduate student, Univ. de Alcalá de Henares, Spain)
Past lab members
Dr. Diego Clemente López (postdoctoral researcher); current position: PI of the GNID, Hospital Nacional de Parapléjicos-SESCAM, Toledo, Spain.
Dr. Ana Bribián Arruego (Ph. D student & Ph.D., postdoc); current position: senior postdoc at the Instituto Cajal-CSIC, Madrid, Spain
Dr. Diego García-González (Ph.D. student); current position: postdoctoral researcher at the German Cancer Institute, Heidelberg, Germany.
Dr. Verónica Murcia-Belmonte (Ph.D. student); current position: postdoctoral researcher at the Instituto de Neurociencias/UMH-CSIC, Alicante, Spain
Dr. Eva-M. Medina-Rodríguez (Ph.D. student); current position: postdoctoral researcher at the University of Miami, Miami, USA
Dr. Cristina Ortega Muñoz (Ph.D. and postdoc; current position: postdoctoral researcher at CBM-UAM/CSIC, Cantoblanco (Madrid), Spain
Dr. Paloma Merchán (Ph.D. student); current position: postdoctoral researcher at the Cincinnati Children´s Hospital, Cincinnati, USA
Dr. Virginia Vila del Sol (postdoctoral researcher); current position: Chief of the Servicio de Citometría, Hospital Nacional de Parapléjicos, Toledo, Spain
F. Javier Arenzana (Ph.D., postdoc)
Dr. Verónica Moliné-Velázquez (Ph.D student); current institution: Universidad de Granada
Dr. Pedro F. Esteban Ruiz (postdoctoral researcher); current position: postdoctoral fellow at Hospital Nacional de Parapléjicos, Toledo, Spain
Publications
Publications
- Medina-Rodríguez EM*, Bribián A*, Boyd A, Pastor J, Lagares A, Gil C, Martínez A, Williams A, & de Castro F (2017) New small phosphodiesterase 7 blockers effectively promote remyelination in vivo and open new neuroreparative strategies for clinical use in Multiple Sclerosis. Sci. Rep. 7, 43545 (doi: 10.1038/srep43545).
- Leonetti C, Macrez R, Pruvost M, Bronsard J, Fournier A, Perrigault M, Vivien D, Clemente D, de Castro F, Maubert E*, & Docagne F* (2017) Tissue plasminogen activator exerts chemokinetic effects on oligodendrocytes in white matter (re)myelination. Molecular Neurodegeneration 12:20 (DOI: 10.1186/s13024-017-0160-5).
- Pintado-Sierra, M., García-Álvarez, I., Bribián, A., Medina-Rodríguez, E.M., Lebrón-Aguilar, R., Garrido, L., de Castro, F., Fernández-Mayoralas, A., & Quintanilla-López, J.E. (2017) A comprehensive profiling of sulfatides in myelin from mouse brain using liquid chromatography-tandem mass spectrometry and high resolution accurate mass spectrometry. Analyt. Chim. Acta 951, 89-98.
- Marín-Bañasco, C., Benabdellah, K., Melero-Jerez, C., Oliver, B., Pinto-Medel, M.J., Hurtado-Guerrero, I., de Castro, F., Clemente, D., Fernández, Ó., Martin, F., Leyva, L., & Suardíaz-García, M. (2017) Gene therapy with mesenchymal stem cells expressing IFNß ameliorates neuroinflammation in experimental models of Multiple Sclerosis. Br. J. Pharmacol. 174, 238-253 (doi: 10.1111/bph.13674).
- de Castro, F. (2017) Human adult Oligodendrocyte Precursor Cell biology: the bottleneck for effective pro-remyelinating therapies for Multiple Sclerosis. In: Converging Clinical and Engineering Research on Neurorehabilitation (Editors: J.L. Pons & XXX) Springer International Publishing. Vol. II, 67-68.
- de Castro, F., Seal, R., y Maggi, R. (2016) ANOS1: a unified nomenclature for Kallmann syndrome 1 gene (KAL1) and anosmin-1. Brief. Funct. Genom. (In Press, BFGP-16-0031).
de Castro, F., & Merchán, M.A. (2016) Editorial: The major discoveries of Cajal and his disciples: Consolidated milestones for the Neuroscience of the XXIst century. Front. Neuroanat. 10:85 (doi: 10.3389/fnana.2016.00085). - Suardíaz, M., Clemente, D., Marín-Bañasco, C., Orpez, T., Guerrero-Hurtado, I., Pavía, P., Pinto-Medel, M.J., de Castro, F., Leyva, L., Fernández, Ó, & Oliver, B. (2016) Recombinant soluble IFN receptor (sIFNAR2) exhibits intrinsic therapeutic efficacy in a murine model of Multiple Sclerosis. Neuropharmacology 110, 480-492. (doi: 10.1016/j.neuropharm.2016.07.026).
- Sierra A, de Castro F, del Río-Hortega J, Iglesias-Rozas J, Garrosa M, & Kettenmann H (2016) The `big-bang´ for modern glial biology: translation and comments on Pío del Río-Hortega 1919 series of papers on microglia. Glia, 64:1801–1840 (doi:10.1002/glia.23046). “Cover page” selected for Volume 64 (Issue 11, pages 1795–2040). Recommended in F1000Prime as being of special significance in its field (http://f1000.com/prime/726748849?bd=1).
- Macrez*, R., Ortega*, M.C., Bardou, I., Mehra, A., Fournier, A., Van der Pol, S.M.A., Haelewyn, B., Maubert, E., Lesept, F., Chevilley, A., de Castro, F., De Vries, H.E., Vivien, D., Clemente*, D., & Docagne*, F. (2016) Neuroendothelial NMDA receptors as therapeutic targets in experimental autoimmune encephalomyelitis. Brain 139; 2406–2419 (doi: http://dx.doi.org/10.1093/brain/aww172).
- de Castro, F. (2016) The Cajal School in the peripheral nervous system: the transcendent contributions of Fernando de Castro on the microscopic structure of sensory and autonomic motor ganglia. Front. Neuroanat. 10:43 (1-11) (doi: 10.3389/fnana.2016.00043).
- de Castro, F., & López-Mascaraque, L. (2016) Olfactory system embryonic development. In: Kaufman’s Atlas of Mouse Development Supplement: With Coronal Sections (ISBN: 978-0-12-800043-4; editors: R. Baldock, J. Bard, D.C. Davidson & G. Morriss-Kay). Pp. 286-292. Academic Press-Elsevier, USA/UK (doi: http://dx.doi.org/10.1016/B978-0-12-800043-4.00022-1).
- García-González, D., Murcia-Belmonte, M., Esteban, P.F., Ortega, F., Díaz, D., Sánchez-Vera, I., Lebrón-Galán, R., Escobar-Castañondo, L., Martínez-Millán, L., Weruaga, E., García-Verdugo, J.M., Berninger, B., & de Castro, F. (2016) Anosmin-1 over-expression increases adult neurogenesis in the subventricular zone and neuroblast migration to the olfactory bulb. Brain Struct. Funct. 221(1):239–260. (doi 10.1007/s00429-014-0904-8; PMID: 25300351).
- Murcia-Belmonte V., Esteban P.F., Martínez-Hernández J., Gruart A., Luján R., Delgado-García J.M., & de Castro F. (2016) Anosmin-1 over-expression regulates oligodendrocyte precursor cell proliferation, migration and myelin sheath thickness. Brain Struc. Funct. 221, 1365-1385 (doi 10.1007/s00429-014-0977-4; PMID: 25662897).
- Moliné-Velázquez, V., Vila-del Sol, V., de Castro, F., & Clemente, D. (2016) Myeloid cell distribution and activity in mutiple sclerosis. Histol. Histopathol. 31, 357-370 (DOI: 10.14670/HH-11-699).
- Merchán, M.A., DeFelipe, J., & de Castro, F. editores (2016) “Cajal and De Castro´s Neurohistological Methods”. Oxford University Press, Oxford (Gran Bretaña). ISBN 978-0-19-022159-1, 252 pages.
- Gutiérrez-Franco, A., Costa, C., Eixarch, H., Castillo, M., Medina-Rodríguez, E.M., Bribián, A., de Castro, F., Montalbán, X., & Espejo, C. (2016) Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: implications for a therapeutic design. Clin. Immunol. 163, 22–33 (doi:10.1016/j.clim.2015.12.005).
- Murcia-Belmonte V., Esteban P.F., Martínez-Hernández J., Gruart A., Luján R., Delgado-García J.M., & de Castro F. (2016) Anosmin-1 over-expression regulates oligodendrocyte precursor cell proliferation, migration and myelin sheath thickness. Brain Struc. Funct. 221, 1365-1385 (doi 10.1007/s00429-014-0977-4; PMID: 25662897).
- García-González, D., Murcia-Belmonte, M., Esteban, P.F., Ortega, F., Díaz, D., Sánchez-Vera, I., Lebrón-Galán, R., Escobar-Castañondo, L., Martínez-Millán, L., Weruaga, E., García-Verdugo, J.M., Berninger, B., & de Castro, F. (2016) Anosmin-1 over-expression increases adult neurogenesis in the subventricular zone and neuroblast migration to the olfactory bulb. Brain Struct. Funct. 221(1):239–260. (doi 10.1007/s00429-014-0904-8; PMID: 25300351).
- Cases, O., Joseph, A., Obry, A., Santin, M.D., Pâques, M., Ben-Yacoub, S., Amsellem, S., Bribián, A., Simonutti, M., Augustin, S., Debeir, T., Sahel, J.-A., Christ, A., de Castro, F., Lehéricy, S., Cosette, P., and Kozyraki, R. (2015). Foxg1-cre mediated Lrp2 inactivation in the developing mouse neural retina, ciliary and retinal pigment epithelia models congenital high myopia. PLOS ONE In Press (PONE-D-14-55738R2).
-
Contact
Where to find us
Developmental neurobiology group-GNDe
Instituto Cajal CSIC. Avda. Doctor Arce, 37. 28002. Madrid
Call us
Phone
Write us
Email address:
Others
Projects
- Grant: “Red Española de Esclerosis Múltiple” -REEM. Financial support: programa ReTics del Instituto de Salud Carlos III (RD12/0032/12). Budget: 34,717€/year From: January 2012 To: December 2016 REEM Coordinator: Dr. Pablo Villoslada. Principal researcher: Dr. Fernando de Castro Soubriet.
- Grant: “Mielina: desde la oligodendrogénesis a las enfermedades desmielinizantes-esclerosis múltiple”. Financial support: Ministerio de Economía y Competitividad-MINECO (SAF2012-40023). Budget: 160,000€ From: January 2013 To: December 2015. Principal researcher: Dr. Fernando de Castro Soubriet
- Grant: “Precursores de oligodendrocitos humanos: purificación y neurobiología como antesala a la terapia celular en esclerosis múltiple”. Financial support: Fundación Eugenio Rodríguez Pascual (Spain). Budget: 20,000 €. From: January 2011 To: December 2013 Principal researcher: Dr. Fernando de Castro Soubriet. Renovated in January 2015 to December 2015 (10,000 €)
- Grant “Targeting tPA/NMDA interactions as a novel strategy of immunointervention in multiple sclerosis”.Financial support: Fondation de l´Association pour la Recherche en l´Esclerose en Plaques-ARSEP (France), Special Call for Proposals “Immunointervention in demyelinating diseases of the Central Nervous System”. Budget: 175,000 € (82,500 € for GNDe). From: March 2012 To February 2014 Principal Researcher: Dr. Fabian Docagne.
- Grant “Targeting tPA/NMDA interactions as a novel strategy of immunointervention in multiple sclerosis”. Financial support: Fondation de l´Association pour la Recherche en l´Esclerose en Plaques-ARSEP (France), Special Call for Proposals “Immunointervention in demyelinating diseases of the Central Nervous System”. Budget: 175,000 € (82,500 € for GNDe). From: March 2012 To February 2014 Principal Researcher: Dr. Fabian Docagne.
- Grant: “Desarrollo de metodología para el diagnóstico y pronóstico de la esclerosis múltiple (ELISA de LCR)”. Financial support: Instituto de Salud Carlos III/Ministerio de Economía y Competitividad-MINECO (Effective measures to stimulate scientific and technological environment of SNS, ADE10-0010). Budget: 350,000 €. From: January 2011 To: December 2013. Principal researcher: Dr. Fernando de Castro Soubriet
- Grant: “Modulación de la proliferación, migración y diferenciación de precursores neurales para neuro-reparación”. Financial support: Consejería de Sanidad de la Junta de Comunidades de Castilla-La Mancha (ICS 06024-00) From: September 2006 To: December 2008. Principal Researcher: Dr. Fernando de Castro
- Grant: ”Reparación de lesiones desmielinizantes con precursores oligodendrogliales y moduladores de su proliferación, migración y diferenciación”. Financial support: Ministerio de Educación-Plan Nacional de Biomedicina (Acción Especial SAF2006-28387-E). From: June 2007 To: June 2008. Pincipal researcher: Dr. Fernando de Castro.
- Grant: “Papel de la interacción de Anosmina/FGFr1 en la migración de precursores de oligodendrocitos”. Financial support: Consejería de Educación y Ciencia de la Junta de Comunidades de Castilla-La Mancha (PAI07-0049-6090). From: January 2007 To: December 2007. Principal researcher: Dr. Pedro F. Esteban
- Financial aid for consolidated groups (Group of Neurobiological Development-GNDe). Financial support: Fundación para la Investigación Sanitaria en Castilla-La Mancha/Fiscam (GCS-2006 C/24). From: May 2007 To: December 2008. Principal researcher: Dr. Fernando de Castro.
- Monetary aid to acquire scientific equipment. Financial support: Fundación para la Investigación Sanitaria en Castilla-La Mancha/Fiscam (EQ-2006/21) From: 2007 To: Principal researcher: Dr. Fernando de Castro.
- Project: “Reparación de lesiones desmielinizantes con precursores oligodendrogliales y moduladores de su proliferación, migración y diferenciación”. Financial support: Ministerio de Educación-Plan Nacional de Biomedicina (SAF2007-65845). From: 2008 To: 2009. Principal researcher: Dr. Fernando de Castro Soubriet
- Project: “Terapia celular en un modelo animal de Esclerosis Múltiple: combinación de precursores oligodendrogliales y células mesenquimales. Estudio del papel del IFN-gamma en la biología del oligodendrocito”. Financial support : Consejería de Educación de la Junta de Comunidades de Castilla-La Mancha (PAI08-0242-3822). From: January 2010 To: December de 2010. Principal researcher: Dr. Fernando de Castro Soubriet
- Project: “Papel de la proteína Anosmina-1 en el desarrollo del sistema olfativo y en neuro-reparación”. Financial support: Fundación para la Investigación Sanitaria en Castilla-La Mancha/Fiscam (PI-2007/66) From: January 2008 To: December 2010. Principal researcher: Dr. Fernando de Castro Soubriet.
- Monetary aid to acquire scientific equipment. Financial support: Fundación para la Investigación Sanitaria en Castilla-La Mancha/Fiscam (EQ-2006/21) From: january 2008. Principal researcher: Dr. Fernando de Castro Soubriet.
- “Red Olfativa Española” – ROE. Financial support: Programa de Acciones Especiales del ministerio de Educación y Ciencia-MEC (BFU2007-30946-E/BFI) budget: 25.000 € From: April 2007 To: April 2008. Principal researcher: Dra. Laura López-Mascaraque
- “Red Española de Esclerosis Múltiple” -REEM. Financial support: programa ReTics del Instituto de Salud Carlos III (RD07/0060/2007) Budget: 34.717€ From: January 2009 To: December 2009. REEM advisor: Dr. Pablo Villoslada. Principal researcher: Dr. Fernando de Castro Soubriet
- Project: “Estudio de la biología de los precursores de oligodendrocitos y sus implicaciones en la patogenia y reparación de la esclerosis múltiple y otras lesiones desmielinizantes” Financial support: Ministerio de Ciencia e Innovación-MICINN (SAF2009-07842). Budget: 180.000€ + FPI associated fellowship From: 2009 To: 2011. Principal researcher: Dr. Fernando de Castro Soubriet
Funding
- Grant: “Red Española de Esclerosis Múltiple” -REEMFinancial support: programa ReTics del Instituto de Salud Carlos III (RD12/0032/12)Budget: 34,717€/year From: January 2012 To: December 2016 REEM Coordinator: Dr. Pablo VillosladaPrincipal researcher: Dr. Fernando de Castro Soubriet
- Grant: “Mielina: desde la oligodendrogénesis a las enfermedades desmielinizantes-esclerosis múltiple”Financial support: Ministerio de Economía y Competitividad-MINECO (SAF2012-40023)Budget: 160,000€ From: January 2013 To: December 2015Principal researcher: Dr. Fernando de Castro Soubriet
- Grant: “Precursores de oligodendrocitos humanos: purificación y neurobiología como antesala a la terapia celular en esclerosis múltiple”Financial support: Fundación Eugenio Rodríguez Pascual (Spain). Budget: 20,000 €From: January 2011 To: December 2013 Principal researcher: Dr. Fernando de Castro SoubrietRenovated in January 2015 to December 2015 (10,000 €)
Neuroscience Research Center dependent on the CSIC. Founded in 1920 and initially directed by Santiago Ramón y Cajal. World reference in the study of the brain. Custodian of the Cajal Legacy.
Activities